Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal Impairment
Clinical trial NCT01830816 · COMPLETED
Trial details
- NCT number
- NCT01830816
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-16
- Primary completion
- 2015-03-03
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.